Rotavirus genotype distribution during the pre-vaccine period in Bolivia: 2007-2008
- PMID: 23688547
- PMCID: PMC3782082
- DOI: 10.1016/j.ijid.2013.03.016
Rotavirus genotype distribution during the pre-vaccine period in Bolivia: 2007-2008
Abstract
Objectives: Rotavirus is the most important etiology of severe diarrhea in Bolivia. The monovalent attenuated human oral rotavirus vaccine Rotarix(®) was introduced in Bolivia in 2008. We describe the molecular epidemiology of circulating rotavirus strains before vaccine introduction.
Methods: Two thousand one hundred thirty-five diarrheal samples were collected from hospitals in four Bolivian cities during 2007-2008. Forty-three percent (445 of 1030 rotavirus-positive samples) were analyzed for G and P genotypes. Among those, 331 were electropherotyped by polyacrylamide gel electrophoresis. Disease severity was quantified using a modified Vesikari scale.
Results: Among the 445 samples, five genotypes were found to be prevalent: G9P[8] (33%), G1P[6] (17%), G2P[4] (13%), G9P[6] (12%), and G1P[8] (4%). Co-infections with two or more strains accounted for 14% of samples. The most prevalent strain, G9, showed greater electropherotype diversity compared to other serogroups. Strain G1P[6] generally infected younger children and peaked later in the year than other strains. No particular genotype was associated with a higher severity score, though there was a significant difference in the duration of diarrhea between genotypes.
Conclusions: During the 2-year pre-vaccine period, substantial diversity of rotavirus co-circulating strains was observed. These data constitute a baseline against which changes in circulating strains post-vaccine introduction can be monitored.
Keywords: Epidemiologic surveillance; Molecular epidemiology; Pediatric diarrhea; Pediatric infectious diseases; Rotavirus.
Copyright © 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Figures
References
-
- Centers for Disease Control and Prevention. Rotavirus surveillance—worldwide, 2001–2008. MMWR Morb Mortal Wkly Rep. 2008;57:1255–7. - PubMed
-
- Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005;15:29–56. - PubMed
-
- Estes MK, Graham DY, Dimitrov DH. The molecular epidemiology of rotavirus gastroenteritis. Prog Med Virol. 1984;29:1–22. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
